Editor’s Note Shareholder payouts by publicly traded healthcare companies have surged 315% since 2001, raising questions about financial priorities in the sector, according to a February 19 article in Healthcare Finance. A research letter published in JAMA Internal Medicine and co-authored by Yale University researchers found that major healthcare corporations…

Read More

Editor’s Note Pregnancy complications—including life-threatening sepsis—surged in Texas after the state banned abortion in 2021, according to a ProPublica analysis of seven years’ worth of state hospital data. In a February 20 report, the outlet details how sepsis rates for women hospitalized after second-trimester pregnancy loss rose by more than…

Read More

Editor's Note Montana legislators are moving to restrict health insurers’ use of prior authorization as frustration over the practice mounts nationwide, KFF News reported February 13. The outlet reports that two Democratic and Republican lawmakers have introduced or are drafting bills for the 2025 Montana Legislature to limit these insurer-mandated…

Read More

Editor's Note As executive director of the Association for Health Care Resource & Materials Management (AHRMM), Michael Schiller, CMRP, gets regular insight into strategies employed by healthcare organizations, suppliers, technology leaders and frontline staff—insight he was happy to share with OR business Management Conference attendees in a February 11 presentation.…

Read More

Editor's Note Jasmine Hampton-Nicholson MSN, RN, CNOR, learned the value of a value analysis team (VAT) the hard way. “I thought that we had a very solid process for our value analysis team,” said the VP of perioperative services at Temple University Health System in a presentation at 2025 OR…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated Baxter Healthcare Corporation’s recall of the Life2000 ventilator system as a Class 1, the most severe category indicating serious risk of injury or death.   According to the agency’s February 5 announcement, a failed operation during manufacturing compromised the operation…

Read More

Editor's Note Moody’s Ratings has shifted the health insurance industry’s credit outlook from stable to negative, according to a February 3 article in Fierce Healthcare. According to the article, the downgrade is due to escalating medical costs that outpace reimbursement rates. Analysts project an 8% rise in commercial market spending…

Read More

Editor's Note The FDA has approved Journavx (suzetrigine), a first-in-class non-opioid analgesic, for the treatment of moderate to severe acute pain in adults. According to the agency’s January 30 announcement, the drug targets sodium channels in the peripheral nervous system to block pain signals before they reach the brain, representing…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated Class 1 Recalls—the most severe category indicating serious risk of injury or death—for multiple devices over the past few days, including pressure monitoring systems, emergency resuscitators, fluid delivery sets, extracorporeal blood circuits, endoscope accessories, infusion pumps, and glucose/Ketone meters. These…

Read More

Ensuring safe, quality care requires precise alignment among inventory levels, delivery schedules, storage solutions, and every other element of the supply chain. A single missing piece of this puzzle—say, a delayed shipment or a storage issue—can disrupt the entire picture. Making the pieces fit can be difficult for any healthcare…

Read More